chrX-108072742-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The ENST00000217957.10(VSIG1):āc.478T>Cā(p.Ser160Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000091 in 1,208,816 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000036 ( 0 hom., 2 hem., cov: 22)
Exomes š: 0.0000064 ( 0 hom. 3 hem. )
Consequence
VSIG1
ENST00000217957.10 missense
ENST00000217957.10 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 0.0350
Genes affected
VSIG1 (HGNC:28675): (V-set and immunoglobulin domain containing 1) This gene encodes a member of the junctional adhesion molecule (JAM) family. The encoded protein contains multiple glycosylation sites at the N-terminal region, and multiple phosphorylation sites and glutamic acid/proline (EP) repeats at the C-terminal region. The gene is expressed in normal stomach and testis, as well as in gastric, esophageal and ovarian cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG1 | NM_182607.5 | c.478T>C | p.Ser160Pro | missense_variant | 4/7 | ENST00000217957.10 | NP_872413.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG1 | ENST00000217957.10 | c.478T>C | p.Ser160Pro | missense_variant | 4/7 | 1 | NM_182607.5 | ENSP00000217957 | P2 | |
VSIG1 | ENST00000415430.7 | c.586T>C | p.Ser196Pro | missense_variant | 5/8 | 2 | ENSP00000402219 | A2 | ||
VSIG1 | ENST00000485533.1 | n.314T>C | non_coding_transcript_exon_variant | 3/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000360 AC: 4AN: 111240Hom.: 0 Cov.: 22 AF XY: 0.0000599 AC XY: 2AN XY: 33414
GnomAD3 genomes
AF:
AC:
4
AN:
111240
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33414
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183485Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67917
GnomAD3 exomes
AF:
AC:
1
AN:
183485
Hom.:
AF XY:
AC XY:
1
AN XY:
67917
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000638 AC: 7AN: 1097576Hom.: 0 Cov.: 29 AF XY: 0.00000827 AC XY: 3AN XY: 362944
GnomAD4 exome
AF:
AC:
7
AN:
1097576
Hom.:
Cov.:
29
AF XY:
AC XY:
3
AN XY:
362944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000360 AC: 4AN: 111240Hom.: 0 Cov.: 22 AF XY: 0.0000599 AC XY: 2AN XY: 33414
GnomAD4 genome
AF:
AC:
4
AN:
111240
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | The c.586T>C (p.S196P) alteration is located in exon 5 (coding exon 5) of the VSIG1 gene. This alteration results from a T to C substitution at nucleotide position 586, causing the serine (S) at amino acid position 196 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Benign
T;T
Sift4G
Uncertain
D;D
Polyphen
0.99
.;D
Vest4
MutPred
0.44
.;Loss of stability (P = 0.1395);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at